Mile High State Consumed $10 Billion Dollars Of Cannabis
0.8 min readPublished On: February 15th, 2021By News Team
DENVER – Colorado cannabis businesses have cumulatively sold $10 billion of cannabis since 2014, according to new data released by the Colorado Department of Revenue (CDOR) on Tuesday. As of January, the state has collected $1.63 billion in tax and revenue fees since 2014, according to the data.
Data from the department shows Colorado ended 2020 with nearly $9.98 billion in total cannabis sales cumulatively. Spurred, no doubt, by stocking up during the COVID-19 pandemic, 2020 was a record-breaking year for Colorado cannabis. The state sold $2.19 billion in cannabis products, a 25% increase from the previous year.
The new year looks to continue the trend. Cannabis sales in Colorado in January – combined medical and recreational –continue to impress with recorded sales of almost $140M in that month alone. Most of the sales are from Denver area which also has the most dispensaries.
Newsteam at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.
CHESANING, Mich. - High Life Farms, a multi-state cannabis company with operations in Michigan and California, announced that its best-selling line of Nuggies chocolate-covered pretzel edibles is now available in California. The product expansion marks ...
DENVER - Business intelligence from Akerna (Nasdaq: KERN), an enterprise software company and the developer of technology infrastructure, ecosystem, and compliance gateway powering the global cannabis industry, analyzed the under 30 age range of cannabis ...
TALLAHASSEE, Fla. - Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), the multi-state operator (MSO) in the United States, announced the reopening of three medical marijuana dispensaries in Miami, Florida. The locations were formerly branded as ...
DISCLAIMER NOTE: This email should be considered strictly private and confidential. Sender of this email is not a United States Securities Dealer, nor Broker, nor U.S. Investment Adviser. Sender is a Registered Corporation and Consultant, and makes no warranties, nor representations as to the buyer, seller, or transaction. Furthermore, this email includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Read more